Eyecity.com Inc (ICTY): True, I read your post earlier...I was j...

True, I read your post earlier...I was just

pinkslipjunkie · 2024-12-19T16:46:45.7970000Z

True, I read your post earlier...I was just hoping that the announced acquisition was signed a lot earlier than the announcement meaning that the documents have been complete and in process for a time now with the OTCMarkets...I know it probably couldn't be done that way but damn BBW...can I at least hope...LOL...;-)

Play Episode

7min

Proactive - Interviews for investors

Clinical study SKNJCT-003 shows positive trends as company advances skin cancer research in UAE

Medicus Pharma CEO Dr. Raza Bokhari joined Steve Darling from Proactive to share updates on the ongoing SKNJCT-003 clinical study, which is being conducted at nine sites across the United States and aims to randomize 60 patients. An interim analysis conducted after enrolling more than half of the targeted participants has shown encouraging results. The study reports a clinical clearance rate exceeding 60%, with the investigational therapy demonstrating strong tolerability across both tested dosage levels. Notably, no dose-limiting toxicities (DLTs) or serious adverse events (SAEs) have been observed, and there have been no systemic effects or clinically significant abnormalities in laboratory results, ECGs, vital signs, or physical exams. These promising findings will be submitted to the U.S. Food and Drug Administration (FDA) as part of a Type C meeting request in Q2 2025. In parallel, the company is advancing its clinical initiatives for non-invasive basal cell carcinoma treatment with a newly proposed study. This randomized, double-blind, placebo-controlled, multi-center trial has been submitted for approval to the UAE Department of Health. The study aims to enroll up to 36 patients at prominent medical institutions, including Cleveland Clinic Abu Dhabi, Sheikh Shakbout Medical City, Burjeel Medical City, and the American Hospital of Dubai. Participants will be assigned in a 1:1:1 ratio to receive either a placebo or one of two dosage levels of the experimental treatment. This expansion into the UAE represents a significant step forward in the company’s mission to develop innovative, non-invasive therapies for skin cancer, broadening its global clinical footprint and reinforcing its commitment to advancing patient care. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer #HealthcareInnovation #Investing #MedicalResearch

Proactive - Interviews for investors

Astral Resoures’ pre-feasibility study on track for June

Astral Resources NL (ASX:AAR) managing director Marc Ducler talked with Proactive about the latest gold recovery results from the Mandilla Gold Project in Western Australia. He shared insights into recent metallurgical test work at the Theia prospect, where 87% gravity recovery and 98% overall recovery were achieved within 24 hours. Ducler highlighted that these strong results support the upcoming mineral resource estimate and pre-feasibility study. The company is optimising the resource estimate using a A$3,500 gold price and current mining and processing cost assumptions. The updated resource model is expected within two weeks, with the pre-feasibility study targeted for release in the June quarter. Ducler also provided an update on Astral’s takeover of Maximus Resources, which has reached a 72% acceptance level. The acquisition adds 330,000oz to Astral’s resource base and provides future infrastructure opportunities. Additionally, the company has active drilling programs, including diamond drilling at Camp Man, an air core program at Feysville, and a 46-hole RC drilling campaign set to begin shortly. For more insights from Astral Resources, visit Proactive’s YouTube channel. Don’t forget to like the video, subscribe, and enable notifications for future updates.

Proactive - Interviews for investors

Europa Oil & Gas CEO on Cloughton planning application and community engagement

Europa Oil & Gas (Holdings) Plc (AIM:EOG) CEO Will Holland talked with Proactive's Stephen Gunnion about the company's submission of a planning application for the Cloughton appraisal well in Yorkshire. The application seeks approval to drill and test a gas field originally discovered in 1986. Holland explained that advancements in technology and improved gas prices now make it viable to extract gas at commercial rates. The appraisal well will determine the feasibility of full-field development. He also discussed the launch of a dedicated community engagement website, designed to provide local stakeholders with transparent information, including independent environmental and regulatory reports. Holland emphasised that the project follows strict UK regulations and aims to minimise environmental impact. Addressing concerns, he clarified that fracking is not involved, citing confirmation from Energy Minister Michael Shanks. He also noted that increased heavy goods vehicle (HGV) traffic would be minimal, at around 1% during operations. Holland stressed the project's potential benefits, including job creation and reducing the UK's reliance on imported liquefied natural gas (LNG). “If you're concerned about the environment, you should be supporting domestic gas production. And that's exactly what this is,” he stated. For more interviews with industry leaders, visit Proactive’s YouTube channel. Don't forget to like this video, subscribe, and turn on notifications for updates! #EuropaOilAndGas #EnergySecurity #NaturalGas #UKGas #CloughtonWell #EnergyTransition #Investing #OilAndGas #SustainableEnergy #LNG

Proactive - Interviews for investors

Nostra Terra Oil and Gas completes fundraise as it advances Pine Mills workovers

Nostra Terra Oil and Gas Company PLC (AIM:NTOG, OTC:NTOGF) CEO Paul Welch talked with Proactive's Stephen Gunnion about the company’s latest developments, including its recently completed £500,000 fundraise. The funds will be used to complete the phase two workover program at Pine Mills, addressing well integrity issues and optimising oil production. Welch highlighted that the company is currently profitable at existing oil prices and remains focused on maximising the potential of Pine Mills before exploring new opportunities. He also discussed the ongoing technical evaluation of the Fouke three location with their partner, with further updates expected. Welch noted that the water flood program, which restarted in September, has exceeded expectations, leading to increased oil production. As a result, part of the funds raised will go towards upgrading two pumping units to support higher output. Looking ahead, Welch emphasised that Nostra Terra is focused on maintaining a solid, profitable base while evaluating further growth opportunities. He pointed out that the company has additional behind-pipe opportunities and untapped potential within Pine Mills, positioning it for continued success. For more updates on Nostra Terra Oil and Gas, visit Proactive's YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for more interviews and insights. #NostraTerra #OilAndGas #EnergyInvesting #OilProduction #Fundraising #Investing #StockMarket #EnergySector #OilIndustry #TexasOil

Followers	246
Posts	29301
Boards Moderated	0
Alias Born	07/08/2009

Volume:	13,351,443
Day Range:	0.0003 - 0.0003
Bid:	0.0002
Ask:	0.0003
Last Trade Time:	2:57:00 PM EDT
Total Trades:	5

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

ICTY Detailed Quote

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Go Ad-Free